Neuroprotection by nicotine against hypoxia-induced apoptosis in cortical cultures involves activation of multiple nicotinic acetylcholine receptor subtypes

Molecular and Cellular Neuroscience

Volumn 24, Issue 3, 2003, Pages 779-786

  Hejmadi, M V ^a   Dajas Bailador, F ^a   Barns, S M ^a   Jones, B ^a,b   Wonnacott, S ^a  

^a University of Bath   (United Kingdom)

^b CLARE COLLEGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA BUNGAROTOXIN; ATROPINE; CASPASE 3; CASPASE 7; DIHYDRO BETA ERYTHROIDINE; NICOTINE; NICOTINIC RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN CORTEX; BRAIN HYPOXIA; CELL SUBPOPULATION; CONTROLLED STUDY; DNA DAMAGE; DNA STRAND BREAKAGE; EMBRYO; ENZYME ACTIVITY; INCUBATION TIME; NERVE CELL NECROSIS; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE CULTURE;

EID: 0344305404     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1044-7431(03)00244-6     Document Type: Article

References (57)

1. Banasiak K.J., Xia Y., Haddad G.G. Mechanisms underlying hypoxia-induced neuronal apoptosis. Prog. Neurobio. 62:2000;215-249.
2. Belluardo N., Mudo G., Blum M., Fuxe K. Central nicotinic receptors, neurotrophic factors and neuroprotection. Behav. Brain Res. 113:2000;21-34.
3. Blancher C., Harris A.L. The molecular basis of the hypoxia response pathway tumour hypoxia as a therapy target . Cancer Metast. Rev. 17:1998;187-194.
4. Chavez-Noriega L.E., Gillespie A., Stauderman K.A., Crona J.H., Claeps B.O., Elliott K.J., Reid R.T., Rao T.S., Velicelebi G., Harpold M.M., Johnson E.C., Corey-Naeve J. Characterization of the recombinant human neuronal nicotinic acetylcholine receptors alpha3beta2 and alpha4beta2 stably expressed in HEK293 cells. Neuropharmacology. 39:2000;2543-2560.
5. Chazot P.L., Godukhin O.V., McDonald A., Obrenovitch T.P. Spreading depression-induced preconditioning in the mouse cortex differential changes in the protein expression of ionotropic nicotinic acetylcholine and glutamate receptors . J. Neurochem. 83:2002;1235-1238.
6. Chen J., Jin K.L., Chen M.Z., Pei W., Kawaguch i K., Greenberg D.A., Simon R.P. Early detection of DNA strand breaks in the brain after transient focal ischemia implications for the role of DNA damage in apoptosis and neuronal cell death . J. Neurochem. 69:1997;232-245.
7. Choi D.W. Excitotoxicity, apoptosis, and ischemic stroke. J. Biochem. Mol. Biol. 34:2001;8-14.
8. Chu D., Qiu J.X., Grafe M., Fabian R., Kent T.A., Rassin D., Nesic O., Werrbach-Perez K., Perez-Polo R. Delayed cell death signaling in traumatized central nervous system hypoxia . Neurochem. Res. 27:2002;97-106.
9. Clarke P.B.S., Pert A. Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic-neurons. Brain Res. 348:1985;355-358.
10. Cordero-Erausquin M., Marubio L.M., Klink R., Changeux J.P. Nicotinic receptor function new perspectives from knockout mice . Trends Pharmacol. Sci. 21:2000;211-217.
11. Costa G., Abin-Carriquiry J.A., Dajas F. Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra. Brain Res. 888:2001;336-342.
12. 2+ dependent mechanism. Neuropharmacology. 39:2000;2799-2807.
13. Dajas-Bailador F.A., Soliakov L., Wonnacott S. Nicotine activates the extracellular signal-regulated kinase 1/2 via the alpha 7 nicotinic acetylcholine receptor and protein kinase A, in SH-SY5Y cells and hippocampal neurones. J. Neurochem. 80:2002;520-530.
14. Dineley K.T., Westerman M., Bui D., Bell K., Ashe K.H., Sweatt J.D. Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha 7 nicotinic acetylcholine receptors in vitro and in vivo mechanisms related to Alzheimer's disease . J. Neurosci. 21:2001;4125-4133.
15. Donnelly-Roberts D.L., Brioni J.D. Pre-clinical evidence on the neuroprotective effects of nicotinic ligands. Arneric S.P., Brioni J.D. Neuronal Nicotinic Receptors Pharmacology and Therapeutic Opportunities . 1999;337-348 Wiley-Liss, New York.
16. Donnelly-Roberts D.L., Xue I.C., Arneric S.P., Sullivan J.P. In vitro neuroprotective properties of the novel cholinergic channel activator (ChCA), ABT-418. Brain Res. 719:1996;36-44.
17. Grow J., Barks J.D.E. Pathogenesis of hypoxic-ischemic cerebral injury in the term infant current concepts . Clin. Perinatol. 29:2002;585-596.
18. Han B.H., Xu D.G., Choi J.J., Han Y.X., Xanthoudakis S., Roy S., Tam J., Vaillancourt J., Colucci J., Siman R., Giroux A., Robertson G.S., Zamboni R., Nicholson D.W., Holtzman D.M. Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injury. J. Biol. Chem. 277:2002;30128-30136.
19. Harvey S.C., Maddox F.N., Luetje C.W. Multiple determinants of dihydro-beta-erythroidine sensitivity on rat neuronal nicotinic receptor alpha subunits. J. Neurochem. 67:1996;1953-1959.
20. Hejmadi M.V., McKeown S.R., Friery O.P., Mclntyre I.A., Patterson L.H., Hirst D.G. DNA damage following combination of radiation with the bioreductive drug AQ4N possible selective toxicity to oxic and hypoxic tumour cells . Br. J. Cancer. 73:1996;499-505.
21. Holladay M.W., Dart M.J., Lynch J.K. Neuronal nicotinic acetylcholine receptors as targets for drug discovery. J. Med. Chem. 40:1997;4169-4194.
22. 2 deprivation in the human and rat. J. Neurophysiol. 68:1992;2165-2173.
23. Johnston M.V., Nakajima W., Hagberg H. Mechanisms of hypoxic neuro degeneration in the developing brain. Neuroscientist. 8:2002;212-220.
24. Kaneko S., Maeda T., Kume T., Kochiyama H., Akaike A., Shimohama S., Kimura J. Nicotine protects cultured cortical neurons against glutamate-induced cytotoxicity via alpha7-neuronal receptors and neuronal CNS receptors. Brain Res. 765:1997;135-140.
25. Khiroug S.S., Harkness P.C., Lamb P.W., Sudweeks S.N., Khiroug L., Millar N.S., Yakel J.L. Rat nicotinic ACh receptor alpha7 and beta2 subunits co-assemble to form functional heteromeric nicotinic receptor channels. J. Physiol. 540:2002;425-434.
26. Kihara T., Shimohama S., Sawada H., Kimura J., Kume T., Kochiyama H., Maeda T., Akaike A. Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity. Ann. Neurol. 42:1997;159-163.
27. Laudenbach V., Medja F., Zoli M., Rossi F.M., Evrard P., Changeux J.P., Gressens P. Selective activation of central subtypes of the nicotinic acetylcholine receptor has opposite effects on neonatal excitotoxic brain injuries. FASEB J. 16:2002;U207-U225.
28. Le D.A., Wu Y.Q., Huang Z.H., Matsushita K., Plesnila N., Augustinack J.C., Hyman B.T., Yuan J.Y., Kuida K., Flavell R.A., Moskowitz M.A. Caspase activation and neuroprotection in caspase-3-deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation. Proc. Natl. Acad. Sci. 99:2002;15188-15193.
29. Loddick S.A., Rothwell N.J. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J. Cereb. Blood Flow Metab. 16:1996;932-940.
30. Luhmann H.J. Ischemia and lesion induced imbalances in cortical function. Prog. Neurobiol. 48:1996;131-166.
31. Luhmann H.J., Kral T. Hypoxia-induced dysfunction in developing rat neocortex. J. Neurophysiol. 78:1997;1212-1221.
32. Mai H.Q., May W.S., Gao F.Q., Jin Z.H., Deng X.M. A functional role for nicotine in Bcl2 phosphorylation and suppression of apoptosis. J. Biol. Chem. 278:2003;1886-1891.
33. Mansvelder H.D., Keath J.R., McGehee D.S. Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron. 33:2002;905-919.
34. Matsuzaki H., Tamatani M., Mitsuda N., Namikawa K., Kiyama H., Miyake S., Tohyama M. Activation of Akt kinase inhibits apoptosis and changes in Bcl-2 and Bax expression induced by nitric oxide in primary hippocampal neurons. J. Neurochem. 73:1999;2037-2046.
35. Morris E.J., Dreixler K.Y., Cheng Y., Wilson P.M., Gin R.M., Geller H.M. Optimisation of single cell gel electrophoresis (SCGE) for quantitative analysis of neuronal DNA damage. Bio Techniques. 26:1999;282-289.
36. Mortimer J.A., Vanduijn C.M., Chandra V., Fratiglioni L., Graves A.B., Heyman A., Jorm A.F., Kokmen E., Kondo K., Rocca W.A., Shalat S.L., Soininen H., Hofman A. Head trauma as a risk factor for Alzheimers Disease - A collaborative reanalysis of case-control studies. International J. Epidemiology. 20:1991;S28-S35.
37. Namura S., Zhu J.M., Fink K., Endres M., Srinivasan A., Tomaselli K.J., Yuan J.Y., Moskowitz M.A. Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J. Neurosci. 18:1998;3659-3668.
38. Nicholson D.W., Thornberry N.A. Caspases killer proteases . Trends Biochem. Sci. 22:1997;299-306.
39. Nicoll J.A., Roberts G.W., Graham D.I. Apolipoprotein-E Epsilon-4 allele is associated with deposition of amyloid beta-protein following head-injury. Nature Medicine. 1(2):1995;135-137.
40. Nieber K. Hypoxia and neuronal function under in vitro conditions. Pharmacol. Ther. 82:1999;71-86.
41. Olive P.L., Durand R.E., Banath J.P., Johnston P.J. Analysis of DNA damage in individual cells. Methods Cell Biol. 64:2001;235-249.
42. O'Neill M.J., Murray T.K., Lakics V., Visanji N.P., Duty S. The role of neuronal nicotinic acetylcholine receptors in acute and chronic neurodegeneration. Curr. Drug Targets CNS Neurol. Disord. 1:2002;399-411.
43. Paschen W., Djuricic B. Comparison of in-vitro ischemia-induced disturbances in energy-metabolism and protein-synthesis in the hippocampus of rats and gerbils. J. Neurochem. 65:1995;1692-1697.
44. Peers C. Hypoxic regulation of ion channel function and expression. Exp. Physiol. 87:2002;413-422.
45. Role L.W., Berg D.K. Nicotinic receptors in the development and modulation of CNS synapses. Neuron. 16:1996;1077-1085.
46. Sahuquillo J., Poca M.A., Amoros S. Current aspects of pathophysiology and cell dysfunction after severe head injury. Curr. Pharm. Design. 7:2001;1475-1503.
47. Semba J., Miyoshi R., Kito S. Nicotine protects against the dexamethasone potentiation of kainic acid-induced neurotoxicity in cultured hippocampal neurons. Brain Res. 735:1996;335-338.
48. Sgonc R., Wick G. Methods for the detection of apoptosis. Int. Arch. Allergy Immun. 105:1994;324-327.
49. Shao Z.Y., Yakel J.L. Single channel properties of neuronal nicotinic ACh receptors in stratum radiatum interneurons of rat hippocampal slices. J. Physiol. London. 527:2000;507-513.
50. Shaw S., Bencherif M., Marrero M.B. Janus kinase 2, an early target of alpha 7 nicotinic acetylcholine receptor-mediated neuroprotection against A beta-(1-42) amyloid. J. Biol. Chem. 277:2002;44920-44924.
51. Shytle R.D., Borlongan C.V., Cahill D.W., Sanberg P.R. Evidence for the neuroprotective actions of nicotine in an in vivo model of excitotoxicity. Med. Chem. Res. 6:1996;555-561.
52. Tohgi H., Utsugisawa K., Nagane Y. Protective effect of nicotine through nicotinic acetylcholine receptor alpha 7 on hypoxia-induced membrane disintegration and DNA fragmentation of cultured PC12 cells. Neurosci. Lett. 285:2000;91-94.
53. Utsugisawa K., Nagane Y., Obara D., Tohgi H. Overexpression of alpha 7 nicotinic acetylcholine receptor prevents G1-arrest and DNA fragmentation in PC12 cells after hypoxia. J. Neurochem. 81:2002;497-505.
54. Walker L.J., Craig R.B., Harris A.L., Hickson I.D. A role for the human DNA-repair enzyme Hap1 in cellular protection against DNA-damaging agents and hypoxic stress. Nucleic Acids Res. 22:1994;4884-4889.
55. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci. 20:1997;92-98.
56. Zamani M.R., Allen Y.S., Owen G.P., Gray J.A. Nicotine modulates the neurotoxic effect of beta-amyloid protein (25-35) in hippocampal cultures. NeuroReport. 8:1997;513-517.
57. Zoli M., Picciotto M.R., Ferrari R., Cocchi D., Changeux J.P. Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors. EMBO J. 18:1999;1235-1244.